Wevelgem, Belgium

Rob De Vreese

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Ghent. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rob De Vreese. Retrieved from https://idiyas.com/inventor/rob-de-vreese

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Ghent, BE (2017)
  • Wevelgem, BE (2018)

Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rob De Vreese: Innovator in HDAC6 Inhibitors

Introduction

Rob De Vreese is a notable inventor based in Wevelgem, Belgium. He has made significant contributions to the field of biochemistry, particularly in the development of selective HDAC6 inhibitors. With a total of 2 patents, his work focuses on innovative methods for treating various diseases.

Latest Patents

Rob De Vreese's latest patents include "Selective HDAC6 inhibitors and uses thereof" and "HDAC6 inhibitors and uses thereof." The first patent relates to selective Histone deacetylase 6 (HDAC6) inhibitors and compositions containing them. It outlines methods for treating diseases where inhibition of HDAC6 is beneficial, such as cell proliferative diseases, autoimmune or inflammatory disorders, and neurodegenerative diseases. The second patent also focuses on HDAC6 inhibitors, detailing methods for treating similar conditions, including viral diseases and malaria.

Career Highlights

Rob De Vreese is affiliated with Universiteit Gent, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community for its potential impact on treating complex diseases.

Collaborations

Rob collaborates with esteemed colleagues such as Matthias D'Hooghe and Marc Bracke, contributing to a dynamic research environment that fosters innovation.

Conclusion

Rob De Vreese stands out as an influential inventor in the realm of HDAC6 inhibitors, with his patents paving the way for advancements in medical treatments. His contributions are vital to the ongoing research in biochemistry and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…